Celgem 200mg Injection is a chemotherapy medication prescribed for various cancers, including non-small cell lung cancer, breast cancer, pancreatic cancer, ovarian cancer, and bladder cancer. It contains Gemcitabine (200mg), a Cytotoxic agent that inhibits DNA synthesis in cancer cells, preventing their replication and spread.
Manufactured by Alkem Laboratories Ltd, this injection is strictly administered under medical supervision. It is an intravenous infusion in hospitals, ensuring controlled and efficacious dosing.
Completing the entire prescribed course is essential for optimal treatment outcomes. Regular blood tests are required to monitor liver and kidney function and blood cell counts during therapy.
This medication is not for self-administration and must only be used under the guidance of a qualified healthcare professional. Before starting Celgem 200 mg, inform your doctor about any ongoing medications, pre-existing liver or kidney conditions, or past chemotherapy treatments to minimize potential risks and complications.
Celgem Injection is a widely used chemotherapy drug that helps manage various cancers through the following mechanisms:
Celgem 200mg Injection is prescription-based and should only be administered by a healthcare professional. General guidelines include:
Celgem 200mg Injection has various strengths and substitutes. Your doctor may adjust your dosage based on your specific condition and response to treatment.
Available strengths include:
| $107.25/ Injection |
Celgem Injection is generally safe when taken as prescribed, but some patients may experience mild to moderate side effects:
Consult your doctor if any side effects persist or worsen over time.
Liver disease
Patients with liver disease should use Celgem Injection with caution. Liver function tests may be necessary before and during treatment.
Kidney impairment
Dose adjustments may be needed in patients with kidney impairment. Regular monitoring is advised to prevent toxicity.
Pregnant and breastfeeding women
Celgem Injection is not recommended during pregnancy or breastfeeding. Discuss alternative treatments with your doctor.
Avoid
Alcohol consumption, driving immediately after administration (may cause dizziness or fatigue), and exposure to infections due to a weakened immune system.
Yes, Celgem 200mg can affect fertility in both men and women. The medication impacts reproductive cells, potentially causing temporary or permanent fertility changes. Patients planning to have children should discuss preservation options with their oncologist before starting treatment.
Yes, Celgem 200 Injection increases the risk of infections. It compromises the immune system by suppressing bone marrow function and lowering white blood cell counts. Practice good hygiene, avoid crowded places, and immediately report any fever or signs of infection.
Yes, Celgem 200mg can cause bleeding and bruising. It reduces platelet counts, which impairs blood clotting. Watch for unusual bruising, prolonged bleeding from cuts, nosebleeds, or bleeding gums, and promptly report these symptoms to your healthcare provider.
Yes, it works effectively in combination with other chemotherapy drugs. Oncologists often pair it with carboplatin or cisplatin to enhance treatment outcomes based on your specific cancer type, stage, and individual factors.
No single timeframe applies to all patients. Celgem 200 Injection typically shows effects over several weeks, with multiple treatment cycles usually required before significant tumor reduction occurs. Regular monitoring helps your oncologist assess and adjust your treatment plan.
While taking Celgem 200 Injection, you can generally continue your regular diet, but following a balanced nutrition plan is advisable. Due to potential immune system suppression, avoid raw or unpasteurized foods that might increase infection risk. Stay well-hydrated and eat smaller, more frequent meals if you experience nausea.